Felix Kreidel

Felix Kreidel

Interventional cardiologist / Cardiologist
UKSH , Campus Kiel - Kiel, Germany

Latest contributions

Mitral interventions: translating the new guidelines into practice

24 Sep 2025

Register for free to this webinar on Wednesday 24 September at 5:00pm (UTC+2) with M. Merx, F. Kreidel and A. Mahabadi and understand current evidence on mitral interventions informing the new ESC guidelines on valvular heart disease, and much more! ...

Diagnostic and therapeutic pathway of a patient with tricuspid regurgitation

27 Nov 2024

Watch the replay of this webinar to learn which patients to refer at what time point for further evaluation of tricuspid regurgitation and so much more!

Featured cases - Tricuspid TEER

26 Nov 2024 – From PCR London Valves 2024

Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of transcatheter edge-to-edge repair (TEER) for the treatment of tricuspid regurgitation. Explore innovative techniques such as the use of the Pascal device in a patient with dextrocardia, the combination...

Featured cases - Tricuspid TEER

What is the future role of 3D ICE in tricuspid valve intervention?

26 Nov 2024 – From PCR London Valves 2024

Discover insights on imaging in tricuspid valve management in this engaging PCR London Valves 2024 roundtable discussion with Jennifer Franke, Felix Kreidel, and Azeem Latib.
Explore the potential of 3D intracardiac echocardiography as a cutting-edge tool for advanced imaging, set to transform clinical practice as it adoption...

What is the future role of 3D ICE in tricuspid valve intervention?

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

25 Nov 2024 – From PCR London Valves 2024

Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

Rapid-fire - Mitral and tricuspid interventions

24 Nov 2024 – From PCR London Valves 2024

Dive into this rapid-fire session featuring selected PCR London Valves 2024 Clinical Cases submissions on mitral and tricuspid interventions. Explore complex cases involving staged TMVR and combined T-TEER with transcatheter atrial septum defect occlusion, managing a pulmonary artery rupture during TTVR, preventing and treating air gas...

Rapid-fire - Mitral and tricuspid interventions

PCR Tricuspid Focus Group - referral meeting in Kiel

26 Jul 2024

Join your peers for this meeting on 11 October 2024 in Kiel, Germany!

How to achieve optimal results in tricuspid valve interventions?

15 May 2024 – From EuroPCR 2024

How to achieve optimal results in tricuspid valve interventions?

Mitral TEER - Part 1

20 Nov 2023 – From PCR London Valves 2023

Gain valuable insights into Mitral Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the prognostic impact of post-procedural mitral regurgitation and gradient after TEER for primary mitral regurgitation and delve into the evolving landscape of same-day discharge following transcatheter edge-to-edge repair.

Mitral TEER - Part 1

Interventional solutions for post-surgical problems

18 May 2023 – From EuroPCR 2023

Experience the cutting-edge world of interventional solutions for post-surgical problems in this session: delve into intriguing cases like acquired left circumflex stenosis after aortic valve surgery presenting as thin cap fibroatheroma, encounter the rare complication of a giant submitral left ventricle pseudo-aneurysm following mitral valve surgery,...

Interventional solutions for post-surgical problems

Treating diverse mitral regurgitation anatomies: the power of versatility

16 May 2023 – From EuroPCR 2023

Based on a LIVE mitral TEER educational procedure and several case examples, this MR patient session will allow you to learn more about the PASCAL platform and system, as well as the latest clinical and real-world data on mitral TEER using the PASCAL system, while benefiting...

Treating diverse mitral regurgitation anatomies: the power of versatility

Use of 4D ICE in tricuspid and mitral valve interventions

16 May 2023 – From EuroPCR 2023

Watch this session to know the challenges of TV imaging, to get an overview on 4D ICE technology, and to study both a transcatheter tricuspid valve procedure and a transcatheter mitral valve procedure through different case presentations, that will then be discussed.

Management of tricuspid valve regurgitation

11 Dec 2022

Watch the replay of the 2nd webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid valve regurgitation'

Mitral annular calcification - From diagnosis to treatment

29 Nov 2022 – From PCR London Valves 2022

Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.

Mitral annular calcification - From diagnosis to treatment

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

28 Nov 2022 – From PCR London Valves 2022

Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

Secondary mitral regurgitation: challenges in management

28 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.

Secondary mitral regurgitation: challenges in management

A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring

28 Nov 2022 – From PCR London Valves 2022

Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Bright future ahead for tricuspid regurgitation management

19 May 2022 – From EuroPCR 2022

In this conversation between Philipp Lurz and Felix Kreidel, recorded for EuroPCR 2022, learn more about the bRIGHT study and the latest outcomes released, and further understand TriClip therapy real-world outcomes applicability in daily practice.

View more videos and course resources here!

Bright future ahead for tricuspid regurgitation management

Tricuspid valve disease: state-of-the-art

23 Nov 2021 – From PCR London Valves 2021

Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...

Tricuspid valve disease: state-of-the-art

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions